newsfilter
← Latest News
PR Newswire·

RegeneRx Consultant to Receive Prestigious Award for Contributions in Field of Health

ROCKVILLE, Md., Feb. 11, 2022 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB:RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair, and regeneration, today announced that Dr. Hynda K. Kleinman, a co